CEL-SCI CORP (CVM) Stock News
NYSEARCA:CVM - NYSE Arca - US1508376076 - Common Stock - Currency: USD
CVM Latest News, Press Relases and Analysis
Keep an eye on the top gainers and losers in Thursday's session.
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.
These stocks are moving in today's session
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Which stocks are gapping on Thursday?
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in today's pre-market session.
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
CEL-SCI Announces Pricing of Public Offering
CEL-SCI Announces Proposed Public Offering
CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia
These stocks are moving in today's session
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
CEL-SCI Announces Combination of Common Stock
CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results
CEL-SCI Announces Closing of $2.5 Million Offering
CEL-SCI Announces Pricing of $2.5 Million Offering
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer
